It got pumped too high initially into a falling metals market and now has come back and started settling in a range - it's not that complicated. If you were really such a genius you would have sold at 60c not on open yesterday.
Time is of the essence? Really. Try and be a bit more emotive. They had $4m cash at end of last quarter and predicted outflow of $2m. I am sure they knew what their plans were for exploration. Should still have $1m left in a month.
But that's not even the point. Would you prefer they sat on the $4m and didn't drill or didn't try and increase land concessions to include the whole resource?
Who cares if they raise $5m at 40c. It's 12.5m shares added to the register. At least they are active. You're problem is you are too focused on day to day prices rather than what the company is achieving. And if you think that's not much I don't know why you are here.
Btw you forgot to substantiate the permit process being "very expensive"
- Forums
- ASX - By Stock
- ADT
- Ann: Adriatic Metals Expands Concession Area at Vares Project
Ann: Adriatic Metals Expands Concession Area at Vares Project, page-26
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADT (ASX) to my watchlist
|
|||||
Last
$3.28 |
Change
-0.310(8.64%) |
Mkt cap ! $926.1M |
Open | High | Low | Value | Volume |
$3.50 | $3.52 | $3.25 | $2.309M | 683.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3024 | $3.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.29 | 9438 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3542 | 3.300 |
7 | 4293 | 3.290 |
13 | 15547 | 3.280 |
6 | 4029 | 3.270 |
7 | 4063 | 3.260 |
Price($) | Vol. | No. |
---|---|---|
3.310 | 1395 | 5 |
3.320 | 3948 | 7 |
3.330 | 31325 | 11 |
3.340 | 3929 | 5 |
3.350 | 3754 | 6 |
Last trade - 10.59am 16/07/2024 (20 minute delay) ? |
Featured News
ADT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online